Nordic Bioscience A/S
Industry
- Biotechnology
- Pharmaceuticals
- In Vitro Diagnostics
Other Names/Subsidiaries
- KeyBioscience AG, Rheoscience, Sanos Bioscience A/S
Latest on Nordic Bioscience A/S
Vivoryon Therapeutics is expected to start enrollment for a Phase IIb trial of its lead Alzheimer’s disease treatment in the second quarter of 2020 in Europe, with topline data due in late-2022. Ulri
The unmet need in non-alcoholic steatohepatitis (NASH) has prompted numerous companies to aggressively pursue the opportunity. And while there is fierce competition to be first to market, the companie
IN VITRO DIAGNOSTICS Mergers & Acquisitions PerkinElmer Inc. EuroImmun AG PerkinElmer Inc. acquired private German company EuroImmun AG (autoimmune, infectious disease, and allergy testing) fo
Nektar Therapeutics used its own expertise in targeting the interleukin-2 (IL-2) receptor for immuno-oncology to rapidly advance another novel compound with a different approach to the target, and n